Wyeth not to sue Sun Pharma over generic Venlafaxine

17 Oct, 2007 The Economic Times

MUMBAI: Sun Pharmaceutical Industries has received a covenant ‘not to sue’ from Wyeth over Sun Pharma’s abbreviated new drug application for generic venlafaxine extended release tablets with multiple para IV certifications.

This ANDA for generic venlafaxine extended release tablets, AB-rated equivalent of Wyeth’s Effexor XR capsules, includes three strengths: 37.5 mg, 75 mg and 150 mg and is based on innovative technology for extended release tablets.

These strengths of Effexor XR capsules annual sales is $2.6 billion in US.

As per the agreement, Wyeth covenants not to sue Sun under any claims of US Patent Nos. 62,74,171, 6,40,13,120 and 64,19,958.

Venlafaxine is an antidepressant of the serotonin-noreplnephrine reuptake inhibitor class.

On Tuesday shares of Sun Pharmaceutical were down by 1.88 per cent at Rs 972 on BSE.

On Tuesday shares of Wyeth shares were down by 0.85 per cent at Rs 474.05 on BSE.

http://economictimes.indiatimes.com/Pharmaceuticals/Wyeth_not_to_sue_Sun_Pharma_over_generic_Venlafaxine/articleshow/2465909.cms

With Thaks from the Economic Times

For any query:
deepakmiglani@hotmail.com